Clinical Trials

NCT Number: NCT06228053 Phase: PHASE2 Trial Summary: The goal of this clinical trial is to study the combination of SX-682 plus enzalutamide in men with metastatic castration resistant prostate cancer (mCRPC) who have failed abiraterone. – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Syntrix Biosystems, Inc. Acronym: SYNERGY-201

NCT Number: NCT06235099 Phase: PHASE3 Trial Summary: This is a prospective, open-label Phase 3 study to evaluate copper Cu 64 PSMA I&T injection for PET/CT imaging in patients with recurrent prostate cancer after radical prostatectomy or radiation ther – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Curium US LLC Acronym: Solar-Recur

NCT Number: NCT06235151 Phase: PHASE3 Trial Summary: This is a prospective, open-label Phase 3 study to evaluate copper Cu 64 PSMA I&T injection for PET/CT imaging in patients with newly diagnosed unfavorable intermediate high-risk, high-risk or very h – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Curium US LLC Acronym: Solar-Stage

NCT Number: NCT05946824 Phase: PHASE2 Trial Summary: There is significant, proven use of radiation for recurrent prostate cancer after surgical resection. This treatment typically is delivered over seven and a half weeks of daily treatments, presenting – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Celcuity Inc Acronym: DASBRT-RPC

NCT Number: NCT05988918 Phase: PHASE2 Trial Summary: This protocol will enroll patients with pancreatic adenocarcinoma and adenosquamous carcinoma (Cohort 1), gastrointestinal/pancreatic neuroendocrine neoplasms with Ki-67 > 20% (Cohort 2) and neuroend – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): University of Michigan Rogel Cancer Center Acronym:

NCT Number: NCT06044025 Phase: PHASE1 Trial Summary: The goal of this clinical trial is to assess the feasibility of adding a combination of metformin and turmeric as part of a nutritional intervention regimen to the current standard of care, namely, in – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): University of Arkansas Acronym:

NCT Number: NCT06049355 Phase: PHASE2 Trial Summary: This phase II trial tests how well an exercise intervention, Exercising Together, works in preventing declines in physical and mental health in couples during radiation treatment for cancer. Treatment – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Fusion Pharmaceuticals Inc. Acronym:

NCT Number: NCT06066437 Phase: PHASE1|PHASE2 Trial Summary: To learn if the proposed dose of 177Lu rhPSMA-10.1 is safe. Phase 2 will open if the Phase 1 dose is found to be safe. To learn about the safety and effects of 177Lu rhPSMA-10.1 alone and with androg – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial […]

NCT Number: NCT06067269 Phase: PHASE2 Trial Summary: This phase II trial evaluates apalutamide in combination with image-guided stereotactic body radiation therapy (SBRT) for the treatment of patients with prostate cancer. Prostate cancer usually needs – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Jonsson Comprehensive Cancer Center Acronym: HEATWAVE

NCT Number: NCT06096870 Phase: PHASE2 Trial Summary: Prostate cancer may return after treatment in 30,000 to 50,000 people each year. There is no clear best way to treat these people. Better treatments are needed. Objective: To test a study – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): National Cancer Institute (NCI) Acronym: